DaVita Sets Ambitious 2030 Community Care Goals After Surpassing Previous ESG Milestones DaVita has unveiled a sweeping new set of 2030 Community Care commitments aimed at transforming kidney care, strengthening communities, advancing teammate opportunities, and accelerating environmental sustainability efforts. The…
Henry Schein Appoints William K. “Dan” Daniel as Independent Chairman Following Stanley Bergman’s Retirement Henry Schein,announced the appointment of William K. “Dan” Daniel as Independent Chairman of the Board, marking a significant leadership transition for one of the world’s largest…
Paralign Health Raises $3 Million Seed Round to Expand EMS-Led Preventive Healthcare Across Rural America Paralign Health, a healthcare technology company focused on connecting underserved patients with preventive healthcare services through Mobile Integrated Health-Community Paramedicine (MIH-CP), has announced the successful…
Pearl Launches AI-Powered RCM Platform to Transform Dental Insurance Workflows and Improve Claim Outcomes Pearl, a global leader in dental artificial intelligence solutions, has introduced Pearl RCM, an advanced revenue cycle management platform designed to modernize the way dental practices…
Kennel Connection Showcases Petwealth Diagnostics at Pet Boarding & Daycare Expo West After Strong Intergroom Debut Kennel Connection, a leading pet care facility management software provider and part of 100GROUP, is expanding its national rollout of an exclusive diagnostic partnership…
Median Technologies to Present AI-Powered Central Imaging and iCRO Services for Oncology Clinical Trials at ASCO 2026 Annual Meeting Median Technologies, a global leader in AI-powered imaging analytics and central imaging services for oncology clinical trials, has announced its participation…
Ebola Crisis Exposes Failures in Global Health Architecture, Says AIDS Healthcare Foundation As Uganda and the Democratic Republic of the Congo (DRC) grapple with a fast-moving Ebola outbreak, the AIDS Healthcare Foundation AIDS Healthcare Foundation (AHF) has warned that the…
Phase 3 Ecopipam Data Show Sustained Tic Improvement and Delayed Relapse in Tourette Syndrome Newly published Phase 3 clinical trial results in JAMA Neurology demonstrate that ecopipam, an investigational first-in-class dopamine D1 receptor antagonist, significantly delayed time to relapse and…
Octave Bioscience Strengthens Precision Neurology Strategy with Appointment of Zachary Fernandes as Vice President of Business Development Octave Bioscience, a commercial-stage precision medicine company dedicated to advancing biomarker-driven solutions for multiple sclerosis (MS), Parkinson’s disease, and other neurodegenerative disorders, has…
Insulet Launches Voluntary Medical Device Correction for Certain Omnipod® Pods Due to Potential Insulin Under-Delivery Risk Insulet Corporation, a leading manufacturer of tubeless insulin delivery systems, has announced a voluntary Medical Device Correction affecting specific lots of Omnipod® 5, Omnipod…